IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
FORT MYERS, FL, Oct. 29, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX:AONC), one of the fastest-growing oncology networks in the United States, has partnered with Vantage Health Technologies to enhance access to and delivery of exceptional cancer care. Vantage's AI-enabled platform provides real-time health data for actionable insights and next-best-actions that can promote better patient experiences and outcomes, reduce provider burnout, and lower the cost of care. The platform also helps AON further enhance its Value-Based Care model in community oncology. "We are pleased to collaborate with Vantage Health Technologies to further enhance our ability to provide excep
CAPE CORAL, FL.,, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX:AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients. The new Cape Coral clinic – located at 326 Del Prado Blvd, Suite 301 – offers Cape Coral-area patients further opportunity to choose a community oncology care practice that best
FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (OTCQX:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13748211. A replay will be available two hours after the call and can be accessed by dialing 1-844-5
INDIANAPOLIS, IN, July 11, 2024 (GLOBE NEWSWIRE) -- Local medical oncologist M. Sarfraz Nawaz, MD, co-authored a quality improvement research project on febrile neutropenia that was accepted and presented at the 21st International Ultmann Chicago Lymphoma Symposium in Chicago, which was held April 19 through April 20. The research project "Neutropenic Patient Care at Ascension St. Vincent Hospital - Indianapolis" investigated improving the care of patients with febrile neutropenia. This dangerous complication in cancer patients increases their risk of serious infections, leading to higher mortality rates among this segment and an increased strain on healthcare resources. This research p
FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (AON) (OTCQX:AONC), a rapidly-growing network of community-based oncology practices, today announced it has qualified to trade on the OTCQX® Best Market. AON previously traded on NASDAQ. The OTCQX Best Market provides value and convenience to U.S. investors, brokers and institutions seeking to trade AONC. The OTCQX Best Market is OTC Markets Group's premier market for established, investor-focused U.S. and international companies. It offers investors transparent trading in companies that meet high financial standards, follow best practice corporate governance, and demonstrate compliance with U.S. securiti
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced American Oncology Network, Inc. (AON) (OTCQX:AONC), a rapidly-growing network of community-based oncology practices, has qualified to trade on the OTCQX® Best Market. American Oncology Network, Inc. previously traded on NASDAQ. American Oncology Network, Inc. begins trading today on OTCQX under the symbol "AONC." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Trading on the OTCQX Market offers companies efficient, cost-effective
FORT MYERS, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's largest and fastest-growing networks of community oncology practices, announced the expansion of its radiation oncology services with the opening of Low Country Radiation in Waycross, Georgia. The clinic can deliver external beam radiation therapy (EBRT), an effective treatment for various cancers. Radiation therapy uses high doses of radiation to kill or slow the growth of cancer cells. When successful, it can shrink early-stage cancer, stop cancer from returning or treat the symptoms associated with cancer metastases. Under AON's leadership and with access to the ne
FORT MYERS, Fla., June 04, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce that several research studies, co-authored by AON physicians and leaders, were accepted at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting. The meeting was held from May 31 to June 4 in Chicago. The following abstracts were selected for either poster discussions, presentations or online publication after rigorous review. Ruemu Ejedafeta Birhiray, MD, of Hematology Oncology of Indiana, co-authored the following studies: "Phase 3 trial evaluating the efficacy and saf
FORT MYERS, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing community oncology networks, today announced the appointment of David Afshar as chief financial and operating officer. "We are pleased to welcome Dave to AON and the leadership team," said Todd Schonherz, AON's chief executive officer. "Over his impressive tenure in healthcare, Dave has built a strong track record, and his expertise in both finance and operations makes him a perfect fit for this essential role. He has developed a deep knowledge of these critical functions and will bring a fresh perspective that will be invaluable as we navigate AON's exci
FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of independent directors. The Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") to delist its Class A common stock and warrants from
CAPE CORAL, FL.,, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX:AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients. The new Cape Coral clinic – located at 326 Del Prado Blvd, Suite 301 – offers Cape Coral-area patients further opportunity to choose a community oncology care practice that best
FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William "Bill" J. Valle to its Board of Directors, effective April 19, 2024. "On behalf of the Board, I am honored to be officially welcoming Bill," said Stephen "Fred" Divers, MD, AON's chief medical officer and vice chairman of the Board. "Bill has extensive experience and knowledge that will help guide AON on its mission forward. His fresh perspectives and insights will serve as a catalyst for innovation as we continue to close the cancer care gap and improve access to c
The innovative healthcare technology startup utilizes data analytics to improve cancer care. Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, is pleased to announce its official launch today and its commitment to transforming oncology, research and patient care. MiBA's debut marks the successful synergistic partnership between industry leaders American Oncology Network (AON) (NASDAQ:AONC) and Ascend Technologies Group (ATG). The company is led by a team of industry visionaries: Todd Schonherz, Mark Moch, Jason Baroff, Scott Newman and Andrew T. Fisher, who collectively bring years of experience in technology, data science and oncology. MiBA's so
WOODLANDS, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of independent oncology practices, is pleased to announce the opening of Woodlands Cancer Institute and welcomes its physicians to the network. Woodlands Cancer Institute is AON's second practice in Texas and first in Montgomery County. The practice specializes in delivering medical oncology, radiation oncology and hematology care and services in a community-based setting. The practice is led by a team of highly skilled Board-certified medical oncologists and one Board-certified radiation oncologist: Eric P. Kleinbaum, MD; Sandeep "Kodi"
FORT MYERS, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC) is pleased to announce its annual Clinical Summit conference, which is scheduled for October 12 through October 15 at the Bellagio Hotel in Las Vegas. The conference brings together the network's healthcare and oncology leaders and physicians from across the nation for a multi-day event. Attendees will discuss and learn about the latest advancements in oncology that will elevate patient care, all under the central theme of "Collaborate, Innovate and Celebrate." In addition to educational sessions and informative AON and industry update breakouts, this year's conference features guest spe
424B3 - American Oncology Network, Inc. (0001839998) (Filer)
10-Q - American Oncology Network, Inc. (0001839998) (Filer)
424B3 - American Oncology Network, Inc. (0001839998) (Filer)
10-Q - American Oncology Network, Inc. (0001839998) (Filer)
424B3 - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
424B3 - American Oncology Network, Inc. (0001839998) (Filer)
8-K - American Oncology Network, Inc. (0001839998) (Filer)
25 - American Oncology Network, Inc. (0001839998) (Filer)
424B3 - American Oncology Network, Inc. (0001839998) (Filer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
3 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (OTCQX:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13748211. A replay will be available two hours after the call and can be accessed by dialing 1-844-5
First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new providers to the AON platform Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (NASDAQ:AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three-month period ("First Quarter 2024") ended March 31, 2024. Todd Schonherz, AONC chief executive officer, commented, "We delivered strong revenue growth in the first qua
FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13746298. A replay will be available two hours after the call and can be accessed by
FORT MYERS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13746298. A replay will be available two hours after the call and can be accessed by dialing 1-844-512
Fiscal Year 2023 Revenue was $1,279.2 million, an 11.3% increase over 2022 Patient encounter growth of 7.9% as compared to the prior fiscal year Fourth Quarter 2023 Revenue was $324.2 million, a 7.9% increase over 2022 Patient encounter growth of 9.5% as compared to the prior year quarter FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- March 28, 2024 – American Oncology Network, Inc. (NASDAQ:AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three- and twelve-month periods ended December 31, 2023. Todd Schonherz, AON chief executive officer, commented, "As a leadership
FORT MYERS, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13744271. A replay will be available two hours after the call and can be accessed by d
Third Quarter 2023 Highlights Revenue of $336.3 million increased by 13.1% compared to the prior year quarter.Successfully transitioned to a publicly traded company with the completion of our business combination with Digital Transformation Opportunities Corp.Expanded into Florida market with Florida Oncology & HematologyExpanded into urology market with Triple Crown Urology in ArkansasAdded 19 new providers to the AON platform FORT MYERS, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (NASDAQ:AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three-month
FORT MYERS, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13741860. A replay will be available two hours after the call and can be accessed by dialing
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to sell up to 75 million shares. GameStop released its first-quarter 2024 results early Friday ahead of its scheduled June 11 date. The company reported net sales of $881.8 million, down from $1.237 billion year-over-year. The net sales total missed a consensus estimate of $995.3 million. The company reported a loss of 12 cents per share, missing the estimate of a loss of 9 cents per share, according to data from Benzinga Pro. GameStop shares dipped 22.5% to $36.07 on Friday. Here are some other stocks moving in today
Gainers Venus Concept (NASDAQ:VERO) shares rose 87.9% to $1.1 during Friday's regular session. The company's market cap stands at $7.0 million. Asensus Surgical (AMEX:ASXC) stock moved upwards by 41.22% to $0.33. The market value of their outstanding shares is at $90.3 million. American Oncology Network (NASDAQ:AONC) shares rose 29.41% to $2.2. The market value of their outstanding shares is at $22.4 million. Anebulo Pharmaceuticals (NASDAQ:ANEB) shares rose 29.33% to $2.8. The market value of their outstanding shares is at $72.6 million. IN8bio (NASDAQ:INAB) stock increased by 22.12% to $1.38. The market value of their outstanding shares is at $60.8 million. Geron (NASDAQ:GERN) stock
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results. G-III Apparel Group posted adjusted earnings of 13 cents per share, according to data from Benzinga Pro. The company's quarterly sales came in at $609.747 million, missing market estimates of $616.286 million. G-III Apparel Group shares dipped 13.4% to $27.12 on Thursday. Here are some other stocks moving in today’s mid-day session. Gainers Virax Biolabs Group Limited (NASDAQ:VRAX) shares jumped 139.4% to $2.5390. American Oncology Network, Inc. (NASDAQ:AONC) gained 102% to $4.52. American Oncology Network expanded
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. The company's market cap stands at $4.7 million. FibroBiologics (NASDAQ:FBLG) shares rose 45.37% to $9.74. The market value of their outstanding shares is at $318.6 million. Aethlon Medical (NASDAQ:AEMD) stock rose 39.58% to $0.61. The company's market cap stands at $3.1 million. American Oncology Network (NASDAQ:AONC) stock rose 32.96% to $3.0. The market value of their outstanding shares is at $30.6 million. Replimune Group (NASDAQ:REPL) shares rose 29.04% to $7.17. The company's market cap stands at $440.6 million. Co-Diagnostics (NASDAQ:CODX) stock rose 27.18% to $1.31. The marke